IHS Chemical Week

Regions :: Western Europe :: U.K.

GSK Acquires Argentine Generics Firm for $253 Million

2:50 AM MDT | June 11, 2010 | Deepti Ramesh

GlaxoSmithKline (GSK; London) says it has acquired Laboratorios Phoenix (Buenos Aires), a leading Argentine pharmaceutical business, for a cash consideration of about $253 million, to accelerate sales growth and further extend its pharmaceutical portfolio in Argentina and the Latin America region. Phoenix is focused on the development, manufacturing, and sale of branded generic products. GSK will gain access to a broad portfolio of branded generic pharmaceutical products covering therapeutic areas including cardiovascular, gastroenterology, metabolic and urology...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa